Flores-Ponce L, Arteaga-Sarmiento P

Language: Spanish
References: 10
Page: 152-156
PDF size: 290.51 Kb.

ABSTRACT

Pulmonary aspergillosis is a fungal infection caused by the fungus Aspergillus. In most cases, it comes from the fumigatus species, a ubiquitous fungus that is acquired by inhaling its spores. The lung is the main organ affected by Aspergillus. Chronic cavitary aspergillosis (previously referred to as complicated aspergilloma) affects immunocompetent patients who develop one or more cavities for several months, usually in the upper lobes, and if they progress they may develop chronic fibrosing forms. This paper reports the case of a female, 67 year-old patient, resident of Mexico City, with a personal history of exposure to passive smoking for 30 years, hypertension under treatment with losartan and amlodipine, without other antecedents of importance. She started her picture 4 months prior to admission with alternating dry cough occasionally with hemoptysis expectoration, as well as intermittent fever. Pulmonary aspergillosis is little common un patients without risk factors and immunocompetent, as in this case, thus, its diagnosis is not easy to suspect and, therefore, the approach must be careful. It is essential that clinicians become familiar with the clinical presentation and diagnostic approach of chronic cavitary pulmonary aspergillosis.

REFERENCES

1. Koren FL, Alonso CS, Alcalá GR, Sánchez NM. Las diferentes manifestaciones de la aspergilosis pulmonar. Hallazgos en tomografía computarizada multidetector. Radiología 2014;56(6):496-504.

2. Valle J, González BF, Alvarez DJ, Valdés CL. La aspergilosis pulmonar invasiva en la enfermedad pulmonar obstructiva crónica. Rev Med Chile 2010;138:612-620.

3. Gassiot NC, Pino AP, Rodríguez VJ, Ramos GM, Páez PI, Gundián GJ. Aspergilosis pulmonar: un nuevo enfoque en la reemergencia. Acta Médica 2000;9(1-2):67-72.

4. Vélez J, Rosso SF. Protocolo de estudio y manejo de pacientes con aspergilosis. Infectio 2012;16:114-117.

5. Díaz SC, López VA. Aspergillus y pulmón. Arch Bronconeumol 2004;40(3):114-22.

6. Oxilia HG, Oxilia RG, Morales L, Falco F. Aspergilosis: una patología a considerar. RAR 2008;72:55-60.

7. Fortún J, Meije Y, Fresco G, Moreno S. Aspergilosis. Formas clínicas y tratamiento. Enferm Infecc Microbiol Clin 2012;30(4):201-208.

8. Cuervo MS, Gómez RJ, Rivas P, Guevara F. Actualización en aspergilosis con énfasis en aspergilosis invasora. Infectio 2010;14:S131-S144.

9. Sherif R, Segal B. Pulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications. Curr Opin Pulm Med 2010;16(3):242-250.

10. Meersseman W, Vandecasteele S, Wilmer A, Verbeken E, et al. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med 2004;170:621-625.